Beruflich Dokumente
Kultur Dokumente
Module 2
Conduction of most impulses from the atria to ventricles is blocked at the atrioventricular (AV) node
AF begets AF
AF causes remodelling that contributes to the initiation and maintenance of AF, including:
Electrical: shortening of atrial refractory period Structural: enlargement of atrial cavities
Initially, many episodes of AF resolve spontaneously Over time, AF tends to become persistent or permanent due to electrical and structural remodelling
Consequences of AF
Formation of blood clots (thrombosis) on the atrial walls that can dislodge (embolize), leading to stroke and systemic embolism Reduction in cardiac output can precipitate heart failure, leading to distinctive symptoms such as:
Peripheral oedema Dyspnoea Pulmonary oedema Fatigue Chest pain
Classification of AF: 2006 joint guidelines of the ACC, AHA and ESC (1)
Classification First detected Recurrent Paroxysmal Persistent Definition First recognized episode of AF 2 episodes of arrhythmia AF that terminates spontaneously AF that persists for >7 days but can be converted with cardioversion AF that cannot be terminated by cardioversion, and long-standing AF (>1 year) where cardioversion not indicated/not attempted
Long-standing persistent
ACC = American College of Cardiology; AHA = American Heart Association; ESC = European Society of Cardiology
Classification of AF: 2006 joint guidelines of the ACC, AHA and ESC (2)
Classification Lone or primary Definition AF without clinical/echo findings of heart disease and age <60 years AF associated with cardiopulmonary disease (e.g. myocardial infarction or pneumonia), cardiac surgery, pericarditis or hyperthyroidism AF that is not associated with damage to the heart valves (e.g. rheumatic mitral valve disease, prosthetic heart valve or mitral valve repair)
Secondary
Non-valvular
ACC = American College of Cardiology; AHA = American Heart Association; ESC = European Society of Cardiology; echo = echocardiogram AHA/ACC/ESC Guidelines. Circulation 2006;114:e257354
10
(usually 48 hrs)
Paroxysmal
Persistent
Long-standing
Permanent
(accepted)
11
Atrial dilatation activating signalling pathways including the RAAS, leading to upregulation of profibrotic factors (e.g. angiotensin II)
Genetic factors e.g. mutations of the lamin A/C gene Inflammatory conditions e.g. pericarditis, sarcoidosis and autoimmune disorders
RAAS = reninangiotensinaldosterone system 1. Burstein B & Nattel S. J Am Coll Cardiol 2008;51:8029; 2. AHA/ACC/ESC Guidelines. Circulation 2006;114:e257354
13
AF alters electrophysiological properties, creating self-perpetuating disturbances in electrical signalling (electrical remodelling)1
14
15
Virchows triad
Atrial fibrillation Left ventricular dysfunction Immobility Venous insufficiency/ varicose veins
Atrial fibrillation Trauma/surgery Atherosclerosis Venopuncture Heart valve disease/ replacement Indwelling catheters
HYPERCOAGULABLE STATE
17
Thrombogenic tendency in AF
The pathogenesis of thromboembolism in AF is complex and multifactorial
Extensive abnormal changes of the atrial wall, blood stasis and blood constituents are clearly evident in patients with AF Thus, AF could drive a prothrombotic or hypercoagulable state by virtue of its fulfilment of Virchows triad for thrombogenesis
18
19
Blood stasis in AF
Stasis is the most important cause of thrombosis in AF Erratic heart contraction reduces flow velocity in the atria (stasis), increasing the risk of thromboembolism Predictors of spontaneous echo contrast, a possible marker of stasis in AF, include:
Left atrial enlargement Reduced left atrial appendage flow velocity Left ventricular dysfunction Fibrinogen level
Haematocrit
echo = echocardiogram AHA/ACC/ESC Guidelines. Circulation 2006;114:e257354
20
1. Blackshear JL & Odell JA. Ann Thorac Surg 1996;61:7559; 2. Stllberger C et al. Ann Intern Med 1998;128:6308
21
Hypercoagulable state in AF
In AF, abnormal changes are evident in:
Platelets and proteins of the coagulation cascade Inflammatory cytokines and growth factors
Presence of a prothrombotic or hypercoagulable state in AF completes Virchows triad Increased thrombogenesis has been reported in acute-onset or chronic AF13
1. Marin F et al. Heart 2004;90:11626; 2. Roldan V et al. Am Heart J 1998;136:95660; 3. Kahn SR et al. Can Med Assoc J 1997;157:67381
22
Appendage
23
24
100
80 Incidence (%) 60
40
20 0
33
29 Men (n=150)
41
36
Women (n=182)
Data from prospective population-based study conducted in Dijon, France (152 606 inhabitants); TOAST = Trial of Org 10172 in Acute Stroke Treatment Bejot Y et al. J Neurol Neurosurg Psychiatry 2008;79:13448
25
Cardiovascular diseases:
Hypertension Diabetes mellitus, insulin resistance and the metabolic syndrome Myocardial infarction Congestive heart failure Valvular disease and heart surgery
27
Thyroid disorders: hyperthyroidism increases the risk of AF 3-fold Inflammation (e.g. myocarditis, pericarditis, systemic inflammation, pneumonia) Sleep apnoea
Sawin CT et al. N Engl J Med 1994;331:124952; Kannel WB & Benjamin EF. Med Clin North Am 2008;92:1740
28
Summary
Summary
AF is characterized by an irregularly irregular heart rate
Classification:
Paroxysmal Persistent Permanent
Causes:
Atrial fibrosis Atrial stretch Pulmonary veins
Thrombi can form on the atrial walls and then dislodge, leading to stroke and systemic embolization Pathogenesis of thromboembolism is complex and multifactorial
30